Literature DB >> 33000378

Is Spreading Depolarization a Risk Factor for Late Epilepsy? A Prospective Study in Patients with Traumatic Brain Injury and Malignant Ischemic Stroke Undergoing Decompressive Craniectomy.

Maria Sueiras1,2,3, Vanessa Thonon4, Estevo Santamarina5, Ángela Sánchez-Guerrero6, Marilyn Riveiro7, Maria-Antonia Poca6,8,9, Manuel Quintana5, Dario Gándara6,9, Juan Sahuquillo6,8,9.   

Abstract

OBJECTIVE: Spreading depolarizations (SDs) have been described in patients with ischemic and haemorrhagic stroke, traumatic brain injury, and migraine with aura, among other conditions. The exact pathophysiological mechanism of SDs is not yet fully established. Our aim in this study was to evaluate the relationship between the electrocorticography (ECoG) findings of SDs and/or epileptiform activity and subsequent epilepsy and electroclinical outcome.
METHODS: This was a prospective observational study of 39 adults, 17 with malignant middle cerebral artery infarction (MMCAI) and 22 with traumatic brain injury, who underwent decompressive craniectomy and multimodal neuromonitoring including ECoG in penumbral tissue. Serial electroencephalography (EEG) recordings were obtained for all surviving patients. Functional disability at 6 and 12 months after injury were assessed using the Barthel, modified Rankin (mRS), and Extended Glasgow Outcome (GOS-E) scales.
RESULTS: SDs were recorded in 58.9% of patients, being more common-particularly those of isoelectric type-in patients with MMCAI (p < 0.04). At follow-up, 74.7% of patients had epileptiform abnormalities on EEG and/or seizures. A significant correlation was observed between the degree of preserved brain activity on EEG and disability severity (R [mRS]: + 0.7, R [GOS-E, Barthel]: - 0.6, p < 0.001), and between the presence of multifocal epileptiform abnormalities on EEG and more severe disability on the GOS-E at 6 months (R: - 0.3, p = 0.03) and 12 months (R: - 0.3, p = 0.05). Patients with more SDs and higher depression ratios scored worse on the GOS-E (R: - 0.4 at 6 and 12 months) and Barthel (R: - 0.4 at 6 and 12 months) disability scales (p < 0.05). The number of SDs (p = 0.064) and the depression ratio (p = 0.1) on ECoG did not show a statistically significant correlation with late epilepsy.
CONCLUSIONS: SDs are common in the cortex of ischemic or traumatic penumbra. Our study suggests an association between the presence of SDs in the acute phase and worse long-term outcome, although no association with subsequent epilepsy was found. More comprehensive studies, involving ECoG and EEG could help determine their association with epileptogenesis.

Entities:  

Keywords:  Decompressive craniectomy; Depolarization; Penumbra; Seizure

Year:  2020        PMID: 33000378     DOI: 10.1007/s12028-020-01107-x

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  44 in total

1.  Spreading and synchronous depressions of cortical activity in acutely injured human brain.

Authors:  Anthony J Strong; Martin Fabricius; Martyn G Boutelle; Stuart J Hibbins; Sarah E Hopwood; Robina Jones; Mark C Parkin; Martin Lauritzen
Journal:  Stroke       Date:  2002-12       Impact factor: 7.914

Review 2.  Clinical relevance of cortical spreading depression in neurological disorders: migraine, malignant stroke, subarachnoid and intracranial hemorrhage, and traumatic brain injury.

Authors:  Martin Lauritzen; Jens Peter Dreier; Martin Fabricius; Jed A Hartings; Rudolf Graf; Anthony John Strong
Journal:  J Cereb Blood Flow Metab       Date:  2010-11-03       Impact factor: 6.200

3.  Cortical spreading depression and peri-infarct depolarization in acutely injured human cerebral cortex.

Authors:  Martin Fabricius; Susanne Fuhr; Robin Bhatia; Martyn Boutelle; Parastoo Hashemi; Anthony J Strong; Martin Lauritzen
Journal:  Brain       Date:  2005-12-19       Impact factor: 13.501

4.  'Malignant' middle cerebral artery territory infarction: clinical course and prognostic signs.

Authors:  W Hacke; S Schwab; M Horn; M Spranger; M De Georgia; R von Kummer
Journal:  Arch Neurol       Date:  1996-04

5.  Spreading depolarisations and outcome after traumatic brain injury: a prospective observational study.

Authors:  Jed A Hartings; M Ross Bullock; David O Okonkwo; Lilian S Murray; Gordon D Murray; Martin Fabricius; Andrew Ir Maas; Johannes Woitzik; Oliver Sakowitz; Bruce Mathern; Bob Roozenbeek; Hester Lingsma; Jens P Dreier; Ava M Puccio; Lori A Shutter; Clemens Pahl; Anthony J Strong
Journal:  Lancet Neurol       Date:  2011-11-03       Impact factor: 44.182

6.  Thresholds in cerebral ischemia - the ischemic penumbra.

Authors:  J Astrup; B K Siesjö; L Symon
Journal:  Stroke       Date:  1981 Nov-Dec       Impact factor: 7.914

Review 7.  The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease.

Authors:  Jens P Dreier
Journal:  Nat Med       Date:  2011-04-07       Impact factor: 53.440

8.  Spreading depolarizations cycle around and enlarge focal ischaemic brain lesions.

Authors:  Hajime Nakamura; Anthony J Strong; Christian Dohmen; Oliver W Sakowitz; Stefan Vollmar; Michael Sué; Lutz Kracht; Parastoo Hashemi; Robin Bhatia; Toshiki Yoshimine; Jens P Dreier; Andrew K Dunn; Rudolf Graf
Journal:  Brain       Date:  2010-05-26       Impact factor: 13.501

9.  Redefining the pericontusional penumbra following traumatic brain injury: evidence of deteriorating metabolic derangements based on positron emission tomography.

Authors:  Hsiao-Ming Wu; Sung-Cheng Huang; Paul Vespa; David A Hovda; Marvin Bergsneider
Journal:  J Neurotrauma       Date:  2013-03-01       Impact factor: 5.269

Review 10.  Recording, analysis, and interpretation of spreading depolarizations in neurointensive care: Review and recommendations of the COSBID research group.

Authors:  Jens P Dreier; Martin Fabricius; Cenk Ayata; Oliver W Sakowitz; C William Shuttleworth; Christian Dohmen; Rudolf Graf; Peter Vajkoczy; Raimund Helbok; Michiyasu Suzuki; Alois J Schiefecker; Sebastian Major; Maren Kl Winkler; Eun-Jeung Kang; Denny Milakara; Ana I Oliveira-Ferreira; Clemens Reiffurth; Gajanan S Revankar; Kazutaka Sugimoto; Nora F Dengler; Nils Hecht; Brandon Foreman; Bart Feyen; Daniel Kondziella; Christian K Friberg; Henning Piilgaard; Eric S Rosenthal; M Brandon Westover; Anna Maslarova; Edgar Santos; Daniel Hertle; Renán Sánchez-Porras; Sharon L Jewell; Baptiste Balança; Johannes Platz; Jason M Hinzman; Janos Lückl; Karl Schoknecht; Michael Schöll; Christoph Drenckhahn; Delphine Feuerstein; Nina Eriksen; Viktor Horst; Julia S Bretz; Paul Jahnke; Michael Scheel; Georg Bohner; Egill Rostrup; Bente Pakkenberg; Uwe Heinemann; Jan Claassen; Andrew P Carlson; Christina M Kowoll; Svetlana Lublinsky; Yoash Chassidim; Ilan Shelef; Alon Friedman; Gerrit Brinker; Michael Reiner; Sergei A Kirov; R David Andrew; Eszter Farkas; Erdem Güresir; Hartmut Vatter; Lee S Chung; K C Brennan; Thomas Lieutaud; Stephane Marinesco; Andrew Ir Maas; Juan Sahuquillo; Markus A Dahlem; Frank Richter; Oscar Herreras; Martyn G Boutelle; David O Okonkwo; M Ross Bullock; Otto W Witte; Peter Martus; Arn Mjm van den Maagdenberg; Michel D Ferrari; Rick M Dijkhuizen; Lori A Shutter; Norberto Andaluz; André P Schulte; Brian MacVicar; Tomas Watanabe; Johannes Woitzik; Martin Lauritzen; Anthony J Strong; Jed A Hartings
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.